Page 9 - Second Genome News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Second Genome To Present Biomarker Data in Oncology at Keystone Symposium --Company Identifies Microbiome-based Composite Biomarker Predictive of Response to Immune Checkpoint Inhibitor-- News provided by Share this article Share this article SAN FRANCISCO, Jan. 19, 2021 /PRNewswire/ -- Second Genome, a leader in microbiome science, will present data today demonstrating the identification of a microbiome-based composite biomarker which can be used to predict response to immune checkpoint inhibitors. The data will be presented at the Keystone Symposium entitled "Harnessing the Microbiome for D...

Pfizer is investing US$25m in a US developer of live biotherapeutics, Vedanta Biosciences; that project is one of four investments, totaling US$120m, made by Pfizer in the second half of 2020 under its breakthrough growth program focused on clinical stage biotech companies of potential future strategic interest to the pharma giant.